The Cliniques universitaires Saint-Luc is a non-profit academic hospital of the University of Louvain, located on the university campus of UCLouvain Bruxelles Woluwe in Woluwe-Saint-Lambert, Brussels, Belgium. The hospital opened on 23 August 1976, moving from Leuven to Brussels.

There are 973 beds in Cliniques Universitaires Saint Luc.

During the past decade, Cliniques Universitaires Saint Luc conducted 608 clinical trials. In the 10-year time frame, 608 clinical trials started and 217 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 201 clinical trials started and 122 clinical trials were completed. i.e. 60.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cliniques Universitaires Saint Luc" #1 sponsor was "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 199 trials, followed by "Hoffmann-La Roche" with 70 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 53 trials sponsored, "Boehringer Ingelheim" with 26 trials sponsored and "Janssen Research & Development, LLC" with 26 trials sponsored. Other sponsors include 662 different institutions and companies that sponsored additional 313 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cliniques Universitaires Saint Luc" #1 collaborator was "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 22 trials as a collaborator, "Merck Sharp & Dohme LLC" with 11 trials as a collaborator, "AstraZeneca" with 10 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 7 trials as a collaborator and "Breast International Group" with 6 trials as a collaborator. Other collaborators include 523 different institutions and companies that were collaborators in the rest 368 trials.

According to Clinical.Site data, the most researched conditions in "Cliniques Universitaires Saint Luc" are "Breast Cancer" (26 trials), "Prostate Cancer" (22 trials), "Multiple Myeloma" (17 trials), "Cystic Fibrosis" (14 trials) and "Head and Neck Cancer" (14 trials). Many other conditions were trialed in "Cliniques Universitaires Saint Luc" in a lesser frequency.

Most popular intervention types in "Cliniques Universitaires Saint Luc" are "Drug" (679 trials), "Other" (143 trials), "Device" (88 trials), "Biological" (81 trials) and "Procedure" (68 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (164 trials), "placebo" (20 trials), "Atezolizumab" (19 trials), "Cisplatin" (17 trials) and "Gemcitabine" (15 trials). Other intervention names were less common.

The vast majority of trials in "Cliniques Universitaires Saint Luc" are 934 trials for "All" genders, 61 trials for "Female" genders and 44 trials for "Male" genders.

Currently, there are 312 active trials in "Cliniques Universitaires Saint Luc". 3 are not yet recruiting, 175 are recruiting, 129 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 511 completed trials in Cliniques Universitaires Saint Luc, 2 suspended trials, and 107 terminated clinical trials to date.

Out of the total trials that were conducted in Cliniques Universitaires Saint Luc, 109 "Phase 1" clinical trials were conducted, 280 "Phase 2" clinical trials and 356 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 37 trials, and there were also 191 trials that are defined as “Not Applicable".

Cliniques Universitaires Saint Luc has several departments that took part in Clinical trials: "Cliniques Universitaires Saint-Luc; Pharmacy" - 5 trials, "Cliniques Universitaires Saint-Luc; Hematology" - 2 trials, "Department of Pneumology Clinique Saint-Luc" - 2 trials